Start for free
Start for free
Charter Life Sciences logo

Charter Life Sciences

North America, California, United States, Santa Clara

Description

Charter Life Sciences is a clinical-stage venture capital firm focused on investments in early-stage opportunities.

Investor Profile

Charter Life Sciences has made 21 investments, with 0 in the past 12 months and 14% as lead.

Stage Focus

  • Series B (48%)
  • Series A (19%)
  • Series Unknown (14%)
  • Series C (10%)
  • Series E (5%)
  • Series D (5%)

Country Focus

  • United States (100%)

Industry Focus

  • Medical
  • Health Care
  • Biotechnology
  • Medical Device
  • Life Science
  • Pharmaceutical
  • Therapeutics
  • Enterprise Software
  • Wellness
  • Manufacturing
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Charter Life Sciences frequently co-invest with?

Canaan Partners
Canaan Partners
North America, California, United States, Menlo Park
Co-Investments: 2
Ascent Biomedical Ventures
Ascent Biomedical Ventures
North America, New York, United States, New York
Co-Investments: 2
Versant Ventures
Versant Ventures
North America, California, United States, Menlo Park
Co-Investments: 3
Venture Investors
Venture Investors
North America, Wisconsin, United States, Madison
Co-Investments: 2
Aperture Venture Partners
Aperture Venture Partners
North America, New York, United States, New York
Co-Investments: 2
Montreux Equity Partners
Montreux Equity Partners
North America, California, United States, San Francisco
Co-Investments: 2
MB Venture Partners
MB Venture Partners
North America, Tennessee, United States, Memphis
Co-Investments: 4
Clarus Ventures
Clarus Ventures
North America, Massachusetts, United States, Cambridge
Co-Investments: 2
Arboretum Ventures
Arboretum Ventures
North America, Michigan, United States, Ann Arbor
Co-Investments: 3
Prism Venture Management
Prism Venture Management
North America, Massachusetts, United States, Needham
Co-Investments: 2

Which angels does Charter Life Sciences often collaborate with?

JH
Shared Deals: 1
SH
Scott Harkonen
North America, California, United States
Shared Deals: 1
MK
Shared Deals: 1
RJ
Shared Deals: 1
John P. Cooke
Shared Deals: 1
JD
Shared Deals: 1

What are some of recent deals done by Charter Life Sciences?

Prevacept Infection Control

Broomfield, Colorado, United States

Prevacept Infection Control is a clinical-stage company focused on developing.

BiotechnologyLife ScienceMedical DevicePharmaceutical
Series UnknownSep 11, 2014
Amount Raised: $11,220,531
Xlumena

Mountain View, California, United States

Xlumena develops products that enable advanced image-guided endoscopic therapy.

Health CareMedicalWellness
Series CDec 3, 2013
Amount Raised: $25,000,000
Amaranth Medical

Mountain View, California, United States

Amaranth Medical provides fully bioresorbable, versatile scaffolds with novel mechanical properties.

BiotechnologyHealth CareMedical
Series BOct 8, 2013
Amount Raised: $20,000,000
Minimally invasive devices

Columbus, Ohio, United States

Minimally Invasive Devices develops surgical tools that facilitate and enable the performance of minimally-invasive surgery.

Enterprise SoftwareMedicalMedical Device
Series BJun 17, 2013
Amount Raised: $2,500,000
Minimally invasive devices

Columbus, Ohio, United States

Minimally Invasive Devices develops surgical tools that facilitate and enable the performance of minimally-invasive surgery.

Enterprise SoftwareMedicalMedical Device
Series BMar 25, 2013
Amount Raised: $9,000,000
Xlumena

Mountain View, California, United States

Xlumena develops products that enable advanced image-guided endoscopic therapy.

Health CareMedicalWellness
Series BApr 29, 2011
Amount Raised: $7,000,000
Prevacept Infection Control

Broomfield, Colorado, United States

Prevacept Infection Control is a clinical-stage company focused on developing.

BiotechnologyLife ScienceMedical DevicePharmaceutical
Series BAug 23, 2010
Amount Raised: $3,100,000
CymaBay Therapeutics

Hayward, California, United States

CymaBay Therapeutics is focused on the development and commercialization of proprietary new medicines for critical human diseases.

BiopharmaBiotechnologyPharmaceutical
Series ENov 5, 2009
Amount Raised: $8,600,000
Inviragen

Fort Collins, Colorado, United States

Inviragen is focused on developing life-saving vaccines to protect against emerging infectious diseases.

BiotechnologyHealth CareMedical
Series AOct 6, 2009
Amount Raised: $15,000,000
Revascular Therapeutics

Sunnyvale, California, United States

Revascular Therapeutics develops solutions for the treatment of total occlusions in arteries.

Health CareMedical DeviceTherapeutics
Series BMay 11, 2009
Amount Raised: $3,000,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator